Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Thomas Finley (NPI 1821201088)

Field	Value
Entity Type	Individual
Organization	Thomas Finley
Address	2424 E 21st St Ste 200
City	Tulsa
State	OK
ZIP	74114
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 7, 2007

Payer Source	Total Paid
Medicare	$4.8M
Medicaid	$0

Key Findings

This provider is effectively single-payer: lifetime Medicare revenue is $4.8M while there is no Medicaid billing on file. The absence of any Medicaid claims indicates the practice’s patient mix and revenue are dominated by Medicare beneficiaries rather than a dual Medicare/Medicaid payer mix.

Revenue is highly concentrated in a small set of injection and retina procedure codes: the precomputed top 3 Medicare codes account for 81.5% of total Medicare revenue, led by J2777 ($2.2M, 44.7%), J0178 ($1.5M, 31.1%), and 67028 ($279K, 5.8%). This concentration shows the majority of billing dollars derive from a few high-value intravitreal and retina procedures.

The CPT/HCPCS mix indicates a retina-focused ophthalmology practice with heavy use of intravitreal biologic agents and advanced retinal imaging. High-volume drug codes (J2777, J0178, J9035) combined with very large volumes of retinal imaging and office E/M (92134 and 92014) point to ongoing medical-retina management rather than a purely refractive or routine general ophthalmology practice.

On competitive standing, the provider is a major national participant for certain retina therapies: J2777 ranks #41 of 2039 providers nationally (98th percentile; notably above typical national volume for this code) and 67028 ranks #85 of 4255 providers nationally (98th percentile; notably above typical national volume for this code). By contrast, J0178 ranks #443 of 3204 providers nationally (86th percentile; typical, unremarkable volume for this code), indicating strong dominance in some newer therapeutics but more moderate positioning for others.

Diagnostic and E/M volumes are extreme outliers relative to peers: 92134 shows 5.2K claims and $139.6K revenue and is labeled an extreme outlier, far above typical national volume for this code, while 92014 has 1.8K claims and $146.8K revenue and is also an extreme outlier, far above typical national volume for this code. Those patterns are consistent with a high-throughput retina clinic that performs frequent imaging and follow-up visits for chronic retinal disease.

The provider has been enumerated on the NPI file since 2007-05-07 (~19 years ago), signaling an established practice footprint that plausibly supports the sustained high volumes observed in injection and imaging codes. Long tenure combined with concentrated, high-volume services suggests an entrenched referral and treatment pathway for retina care.

The payer and service-line concentration create measurable revenue concentration risk: with 81.5% of Medicare revenue coming from the top three codes and no Medicaid revenue reported, the practice is highly dependent on intravitreal drug reimbursement and Medicare coverage trends for those specific agents. Any shifts in utilization patterns, reimbursement, or drug mix for J2777 or J0178 could materially affect total revenue.

Surgical and ancillary retina procedures are present but represent smaller revenue contributions; codes such as 67041, 67036, and 67108 appear with modest revenue shares and generally rank in typical to unremarkable national percentiles. This mix indicates the provider performs some vitreoretinal surgery and ancillary procedures but that the core revenue engine is medical-retina treatment and imaging rather than high-volume surgery.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	74,280	$30	$2.2M
J0178	Injection, aflibercept, 1 mg	2,180	$690	$1.5M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,140	$90	$279K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	820	$220	$177.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,790	$80	$146.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	5,170	$30	$139.6K
J9035	Injection, bevacizumab, 10 mg	1,340	$50	$72.1K
J2778	Injection, ranibizumab, 0.1 mg	380	$180	$69.5K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	440	$100	$41.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	310	$120	$35.8K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Thomas Finley — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	5	30	790	$690	$801.2K
J2777	2	20	23,040	$30	$781.1K
Q5128	2	10	800	$220	$182.2K
J2778	5	10	420	$180	$173.2K
67028	1	40	720	$80	$88.9K
67042	10	10	30	$980	$37.1K
J9035	1	30	330	$50	$23.5K
67036	1	10	20	$900	$19.9K
92235	3	20	60	$100	$19.5K
67108	2	10	20	$1,020	$19.5K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Thomas Finley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Justin Gooden	KS	Undersea and Hyperbaric Medicine (Preventive Medicine) Physician	$4.3M	$0

Nearby Providers

Other providers in the same ZIP code as Thomas Finley, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Family & Children's Services, Inc	OK	Community/Behavioral Health Agency	$0	$77.4M
Justin Parschauer	OK	Ophthalmology Physician	$3.2M	$0
Jerry L Greer Dds PC	OK	Oral and Maxillofacial Surgery (Dentist)	$0	$2.5M
Tulsa Retina Consultants PLLC	OK	Ophthalmology Physician	$0	$2.2M
Family & Children's Services, Inc	OK	Psychiatry Physician	$0	$1.7M
Scott Meyers	OK	MOHS-Micrographic Surgery Physician	$691.4K	$0
Lindsay Cunningham	OK	Rheumatology Physician	$502.1K	$0
Mark Lehman	OK	Dermatology Physician	$350.7K	$0
George Monks	OK	Dermatology Physician	$327.7K	$0
Kelli Lovelace	OK	Dermatology Physician	$267.3K	$0

Thomas Finley — Billing Profile & Reimbursement Data

Sign up for Thomas Finley — Billing Profile & Reimbursement Data policy alerts

Thomas Finley — Billing Profile & Reimbursement Data

Sign up for Thomas Finley — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References